Great chatting with @OncLive about our upcoming #SITC26 presentation!
Excited to share our first-in-human phase 1 results combining PSMA×CD28 costimulation with KLK2×CD3 T-cell engagement in #mCRPC.
Looking forward to tomorrow's presentation!
Excited to share our first-in-human phase 1 results combining PSMA×CD28 costimulation with KLK2×CD3 T-cell engagement in #mCRPC.
Looking forward to tomorrow's presentation!
Thank you to @LauraGrahamMD of @CUCancerCenterView quoted post on X
for stopping by to discuss her @sitcancer
presentation on phase 1 data for the PSMAxCD28 T-cell engager JNJ-87189401 plus pasritamig in mCRPC.
Stay tuned for her presentation on Saturday at #SITC26!